Colossal Biosciences Startups Research and Development Pharmaceutical Companies Investment Clinical Research Funding Startup Companies Start-ups Conservation Startups Clinical Trials Clonorgan Biotechnology Collaborations De-extinction Companies Drug Development Corporate Social Responsibility Pharmaceuticals Gene Editing Companies Regulatory Approval Corporate Sustainability DNA Synthesis Providers Investment in Conservation Partnerships Clinical Development Pest Control Services Investment Strategies Drug Development Costs Commercial Applications Patent Disputes Synthetic Biology Startups Company Profiles Patent Litigation Investment Opportunities Genetic Engineering Firms Commercial-stage Companies Conservation Funding Food Industry Gene Therapy Production Facilities
The study uses a doxycycline-controlled three-gene system to treat glaucoma with a reversible safety switch to limit gene activity.
